This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice.
The new Sequence Rules came into effect on July 1, 2022. This date is crucial for patent applicants dealing with nucleotide and/or amino acid sequences.
As stated in MPEP 2412.01, the rules apply to “patent applications that were filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).” This means that any patent application filed on or after this date must comply with the new sequence listing requirements.